Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids

The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids As a therapeutic agent, most people are familiar with the palliative effects of the primary psychoactive constituent of Cannabis sativa (CS), Δ9-tetrahydrocannabinol (THC), a molecule active at both the cannabinoid 1 (CB1) and cannabinoid 2 (CB2) receptor subtypes. Through the activation primarily of CB1 receptors in the central nervous system, THC can reduce nausea, emesis and pain in cancer patients undergoing chemotherapy. During the last decade, however, several studies have now shown that CB1 and CB2 receptor agonists can act as direct antitumor agents in a variety of aggressive cancers. In addition to THC, there are many other cannabinoids found in CS, and a majority produces little to no psychoactivity due to the inability to activate cannabinoid receptors. For example, the second most abundant cannabinoid in CS is the non-psychoactive cannabidiol (CBD). Using animal models, CBD has been shown to inhibit the progression of many types of cancer including glioblastoma (GBM), breast, lung, prostate and colon cancer. This review will center on mechanisms by which CBD, and other plant-derived cannabinoids inefficient at activating cannabinoid receptors, inhibit tumor cell viability, invasion, metastasis, angiogenesis, and the stem-like potential of cancer cells. We will also discuss the ability of non-psychoactive cannabinoids to induce autophagy and apoptotic-mediated cancer cell death, and enhance the activity of first-line agents commonly used in cancer treatment. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Neuroimmune Pharmacology Springer Journals

The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids

Download PDF
13 pages
Read Article

Loading next page...
 
/lp/springer-journals/the-antitumor-activity-of-plant-derived-non-psychoactive-cannabinoids-cmxY2L7Aev
Publisher
Springer Journals
Copyright
Copyright © 2015 by Springer Science+Business Media New York
Subject
Biomedicine; Neurosciences; Immunology; Pharmacology/Toxicology; Virology; Cell Biology
ISSN
1557-1890
eISSN
1557-1904
DOI
10.1007/s11481-015-9608-y
pmid
25916739
Publisher site
See Article on Publisher Site

Abstract

As a therapeutic agent, most people are familiar with the palliative effects of the primary psychoactive constituent of Cannabis sativa (CS), Δ9-tetrahydrocannabinol (THC), a molecule active at both the cannabinoid 1 (CB1) and cannabinoid 2 (CB2) receptor subtypes. Through the activation primarily of CB1 receptors in the central nervous system, THC can reduce nausea, emesis and pain in cancer patients undergoing chemotherapy. During the last decade, however, several studies have now shown that CB1 and CB2 receptor agonists can act as direct antitumor agents in a variety of aggressive cancers. In addition to THC, there are many other cannabinoids found in CS, and a majority produces little to no psychoactivity due to the inability to activate cannabinoid receptors. For example, the second most abundant cannabinoid in CS is the non-psychoactive cannabidiol (CBD). Using animal models, CBD has been shown to inhibit the progression of many types of cancer including glioblastoma (GBM), breast, lung, prostate and colon cancer. This review will center on mechanisms by which CBD, and other plant-derived cannabinoids inefficient at activating cannabinoid receptors, inhibit tumor cell viability, invasion, metastasis, angiogenesis, and the stem-like potential of cancer cells. We will also discuss the ability of non-psychoactive cannabinoids to induce autophagy and apoptotic-mediated cancer cell death, and enhance the activity of first-line agents commonly used in cancer treatment.

Journal

Journal of Neuroimmune Pharmacology – Springer Journals

Published: Apr 28, 2015

References

  • Interactions of delta 1-tetrahydrocannabinol with cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentography
    Agurell, S; Carlsson, S; Lindgren, JE; Ohlsson, A; Gillespie, H; Hollister, LE
  • Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions
    Albanese, C; Johnson, J; Watanabe, G; Eklund, N; Vu, D; Arnold, A; Pestell, RG
  • 3H-delta 9-Tetrahydrocannabinol, 3H-cannabinol and 3H-cannabidiol: penetration and regional distribution in rat brain
    Alozie, SO; Martin, BR; Harris, LS; Dewey, WL
  • Targeting the endocannabinoid system in cancer therapy: a call for further research
    Bifulco, M; Marzo, V
  • Characterization of cytochrome P450 3A inactivation by cannabidiol: possible involvement of cannabidiol-hydroxyquinone as a P450 inactivator
    Bornheim, LM; Grillo, MP
  • The effects of delta 9-tetrahydrocannabinol alone and in combination with cannabidiol on fixed-interval performance in rhesus monkeys
    Brady, KT; Balster, RL
  • Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition
    Caffarel, MM; Andradas, C; Mira, E; Perez-Gomez, E; Cerutti, C; Moreno-Bueno, G; Flores, JM; Garcia-Real, I; Palacios, J; Manes, S; Guzman, M; Sanchez, C
  • Redox implications of AMPK-mediated signal transduction beyond energetic clues
    Cardaci, S; Filomeni, G; Ciriolo, MR
  • Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes
    Carracedo, A; Gironella, M; Lorente, M; Garcia, S; Guzman, M; Velasco, G; Iovanna, JL
  • The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells
    Carracedo, A; Lorente, M; Egia, A; Blazquez, C; Garcia, S; Giroux, V; Malicet, C; Villuendas, R; Gironella, M; Gonzalez-Feria, L; Piris, MA; Iovanna, JL; Guzman, M; Velasco, G
  • Influence of cannabidiol on delta-9-tetrahydrocannabinol effects
    Dalton, WS; Martz, R; Lemberger, L; Rodda, BE; Forney, RB
  • Cannabinoids inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer cells
    Dando, I; Donadelli, M; Costanzo, C; Dalla Pozza, E; D’Alessandro, A; Zolla, L; Palmieri, M
  • Neurobehavioral actions of cannabichromene and interactions with delta 9-tetrahydrocannabinol
    Davis, WM; Hatoum, NS
  • Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms
    Petrocellis, L; Ligresti, A; Schiano Moriello, A; Iappelli, M; Verde, R; Stott, CG; Cristino, L; Orlando, P; Marzo, V
  • Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism
    Donadelli, M; Dando, I; Zaniboni, T; Costanzo, C; Dalla Pozza, E; Scupoli, MT; Scarpa, A; Zappavigna, S; Marra, M; Abbruzzese, A; Bifulco, M; Caraglia, M; Palmieri, M
  • Structural requirements for cannabinoid activity
    Edery, H; Grunfeld, Y; Ben-Zvi, Z; Mechoulam, R
  • Combined antiproliferative effects of the aminoalkylindole WIN55,212-2 and radiation in breast cancer cells
    Emery, SM; Alotaibi, MR; Tao, Q; Selley, DE; Lichtman, AH; Gewirtz, DA
  • The endocannabinoid system in cancer-potential therapeutic target?
    Flygare, J; Sander, B
  • Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis
    Fong, S; Itahana, Y; Sumida, T; Singh, J; Coppe, JP; Liu, Y; Richards, PC; Bennington, JL; Lee, NM; Debs, RJ; Desprez, PY
  • Antitumorigenic effects of cannabinoids beyond apoptosis
    Freimuth, N; Ramer, R; Hinz, B
  • Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation
    Galve-Roperh, I; Sanchez, C; Cortes, ML; Pulgar, TG; Izquierdo, M; Guzman, M
  • Anxiolytic effect of cannabidiol derivatives in the elevated plus-maze
    Guimaraes, FS; Aguiar, JC; Mechoulam, R; Breuer, A
  • The endocannabinoid system and cancer: therapeutic implication
    Guindon, J; Hohmann, AG
  • ID genes mediate tumor reinitiation during breast cancer lung metastasis
    Gupta, GP; Perk, J; Acharyya, S; Candia, P; Mittal, V; Todorova-Manova, K; Gerald, WL; Brogi, E; Benezra, R; Massague, J
  • Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants
    Hampson, AJ; Grimaldi, M; Axelrod, J; Wink, D
  • Cannabinol and cannabidiol in combination: temperature, open-field activity, and vocalization
    Hiltunen, AJ; Jarbe, TU; Wangdahl, K
  • Behaviour in rats maintained by low differential reinforcement rate: effects of delta 1-tetrahydrocannabinol, cannabinol and cannabidiol, alone and in combination
    Hiltunen, AJ; Jarbe, TU; Kamkar, MR; Archer, T
  • The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells
    Holland, ML; Panetta, JA; Hoskins, JM; Bebawy, M; Roufogalis, BD; Allen, JD; Arnold, JC
  • The multidrug transporter ABCG2 (BCRP) is inhibited by plant-derived cannabinoids
    Holland, ML; Lau, DT; Allen, JD; Arnold, JC
  • Interactions in man of delta-9-tetrahydrocannabinol. II. Cannabinol and cannabidiol
    Hollister, LE; Gillespie, H
  • Cannabinoid inhibition of adenylate cyclase: relative activity of the constituents and metabolites of marijuana
    Howlett, AC
  • The role of Id-1 in chemosensitivity and epirubicin-induced apoptosis in bladder cancer cells
    Hu, H; Han, HY; Wang, YL; Zhang, XP; Chua, CW; Wong, YC; Wang, XF; Ling, MT; Xu, KX
  • Synthesis and pharmacology of a very potent cannabinoid lacking a phenolic hydroxyl with high affinity for the CB2 receptor
    Huffman, JW; Shu, Y; Showalter, V; Abood, ME; Wiley, JL; Compton, DR; Martin, BR; Bramblett, DR; Reggio, PH
  • Evidence that cannabidiol does not significantly alter the pharmacokinetics of tetrahydrocannabinol in man
    Hunt, CA; Jones, RT; Herning, RI; Bachman, J
  • Serum-dependent effects of tamoxifen and cannabinoids upon C6 glioma cell viability
    Jacobsson, SO; Rongard, E; Stridh, M; Tiger, G; Fowler, CJ
  • Inhibition of cyclosporine and tetrahydrocannabinol metabolism by cannabidiol in mouse and human microsomes
    Jaeger, W; Benet, LZ; Bornheim, LM
  • Cannabimimetic activity of cannabinol in rats and pigeons
    Jarbe, TU; Hiltunen, AJ
  • Marihuana: biological effects, analysis, metabolism, cellular responses, reproduction and brain
    Karler, R; Turkanis, SA
  • Cannabinoid-based drugs as anti-inflammatory therapeutics
    Klein, TW
  • Synthesis and antitumor activity of quinonoid derivatives of cannabinoids
    Kogan, NM; Rabinowitz, R; Levi, P; Gibson, D; Sandor, P; Schlesinger, M; Mechoulam, R
  • HU-331, a novel cannabinoid-based anticancer topoisomerase II inhibitor
    Kogan, NM; Schlesinger, M; Priel, E; Rabinowitz, R; Berenshtein, E; Chevion, M; Mechoulam, R
  • Controlling tumor growth by modulating endogenous production of reactive oxygen species
    Laurent, A; Nicco, C; Chereau, C; Goulvestre, C; Alexandre, J; Alves, A; Levy, E; Goldwasser, F; Panis, Y; Soubrane, O; Weill, B; Batteux, F
  • Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma
    Ligresti, A; Moriello, AS; Starowicz, K; Matias, I; Pisanti, S; Petrocellis, L; Laezza, C; Portella, G; Bifulco, M; Marzo, V
  • The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis
    Malfait, AM; Gallily, R; Sumariwalla, PF; Malik, AS; Andreakos, E; Mechoulam, R; Feldmann, M
  • Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3
    Mao, P; Joshi, K; Li, J; Kim, SH; Li, P; Santana-Santos, L; Luthra, S; Chandran, UR; Benos, PV; Smith, L; Wang, M; Hu, B; Cheng, SY; Sobol, RW; Nakano, I
  • Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival
    Marcu, JP; Christian, RT; Lau, D; Zielinski, AJ; Horowitz, MP; Lee, J; Pakdel, A; Allison, J; Limbad, C; Moore, DH; Yount, GL; Desprez, PY; McAllister, SD
  • Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines
    Massi, P; Vaccani, A; Ceruti, S; Colombo, A; Abbracchio, MP; Parolaro, D
  • The non-psychoactive cannabidiol triggers caspase activation and oxidative stress in human glioma cells
    Massi, P; Vaccani, A; Bianchessi, S; Costa, B; Macchi, P; Parolaro, D
  • Cannabidiol as potential anticancer drug
    Massi, P; Solinas, M; Cinquina, V; Parolaro, D
  • Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells
    McAllister, SD; Christian, RT; Horowitz, MP; Garcia, A; Desprez, PY
  • Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis
    McAllister, SD; Murase, R; Christian, RT; Lau, D; Zielinski, AJ; Allison, J; Almanza, C; Pakdel, A; Lee, J; Limbad, C; Liu, Y; Debs, RJ; Moore, DH; Desprez, PY
  • Cannabidiol-induced apoptosis in human leukemia cells: a novel role of cannabidiol in the regulation of p22phox and Nox4 expression
    McKallip, RJ; Jia, W; Schlomer, J; Warren, JW; Nagarkatti, PS; Nagarkatti, M
  • Cannabis and cannabis extract: greater than the sum of the parts?
    McPartland, JM; Russo, EB
  • Identification of a 2-mono-glyceride, present in canine gut, that biinds to cannabinoid receptors
    Mechoulam, R; Ben-Shabat, S; Hanus, S; Ligumsky, M; Kaminski, NE; Schatz, AR; Gopher, A; Almong, S; Martin, BR; Compton, DR; Pertwee, RG; Griffin, G; Bayewitch, M; Barg, J; Vogel, Z
  • Genes that mediate breast cancer metastasis to lung
    Minn, AJ; Gupta, GP; Siegel, PM; Bos, PD; Shu, W; Giri, DD; Viale, A; Olshen, AB; Gerald, WL; Massague, J
  • Targeting multiple cannabinoid antitumor pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer
    Murase, R; Kawamura, R; Singer, E; Pakdel, A; Sarma, P; Judkins, J; Elwakeel, E; Dayal, S; Martinez-Martinez, E; Amere, M; Gujjar, R; Mahadevan, A; Desprez, PY; McAllister, SD
  • Crosstalk between chemokine receptor CXCR4 and cannabinoid receptor CB2 in modulating breast cancer growth and invasion
    Nasser, MW; Qamri, Z; Deol, YS; Smith, D; Shilo, K; Zou, X; Ganju, RK
  • Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking
    Ohlsson, A; Lindgren, JE; Wahlen, A; Agurell, S; Hollister, LE; Gillespie, HK
  • A comparison of the pharmacological activity in man of intraveneously administered D9-tetrahydrocannabinol, cannabinol, and cannabidiol
    Perez-Reyes, M; Timmons, MC; Davis, KH; Wall, EM
  • Pharmacology of cannabinoid CB1 and CB2 receptors
    Pertwee, RG
  • Cannabinoid pharmacology: the first 66 years
    Pertwee, RG
  • The molecular logic of endocannabinoid signalling
    Piomelli, D
  • Inhibitor of differentiation-1 as a novel prognostic factor in NSCLC patients with adenocarcinoma histology and its potential contribution to therapy resistance
    Ponz-Sarvise, M; Nguewa, PA; Pajares, MJ; Agorreta, J; Lozano, MD; Redrado, M; Pio, R; Behrens, C; Wistuba, II; Garcia-Franco, CE; Garcia-Foncillas, J; Montuenga, LM; Calvo, A; Gil-Bazo, I
  • Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis
    Preet, A; Qamri, Z; Nasser, MW; Prasad, A; Shilo, K; Zou, X; Groopman, JE; Ganju, RK
  • Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer
    Qamri, Z; Preet, A; Nasser, MW; Bass, CE; Leone, G; Barsky, SH; Ganju, RK
  • Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1
    Ramer, R; Hinz, B
  • Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1
    Ramer, R; Merkord, J; Rohde, H; Hinz, B
  • Decrease of plasminogen activator inhibitor-1 may contribute to the anti-invasive action of cannabidiol on human lung cancer cells
    Ramer, R; Rohde, A; Merkord, J; Rohde, H; Hinz, B
  • Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1
    Ramer, R; Bublitz, K; Freimuth, N; Merkord, J; Rohde, H; Haustein, M; Borchert, P; Schmuhl, E; Linnebacher, M; Hinz, B
  • COX-2 and PPAR-gamma confer cannabidiol-induced apoptosis of human lung cancer cells
    Ramer, R; Heinemann, K; Merkord, J; Rohde, H; Salamon, A; Linnebacher, M; Hinz, B
  • Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell death
    Rimmerman, N; Ben-Hail, D; Porat, Z; Juknat, A; Kozela, E; Daniels, MP; Connelly, PS; Leishman, E; Bradshaw, HB; Shoshan-Barmatz, V; Vogel, Z
  • Cannabidiol targets mitochondria to regulate intracellular Ca2+ levels
    Ryan, D; Drysdale, AJ; Lafourcade, C; Pertwee, RG; Platt, B
  • Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells
    Salazar, M; Carracedo, A; Salanueva, IJ; Hernandez-Tiedra, S; Lorente, M; Egia, A; Vazquez, P; Blazquez, C; Torres, S; Garcia, S; Nowak, J; Fimia, GM; Piacentini, M; Cecconi, F; Pandolfi, PP; Gonzalez-Feria, L; Iovanna, JL; Guzman, M; Boya, P; Velasco, G
  • Cannabinoid receptor agonist-induced apoptosis of human prostate cancer cells LNCaP proceeds through sustained activation of ERK1/2 leading to G1 cell cycle arrest
    Sarfaraz, S; Afaq, F; Adhami, VM; Malik, A; Mukhtar, H
  • Cannabinoids for cancer treatment: progress and promise
    Sarfaraz, S; Adhami, VM; Syed, DN; Afaq, F; Mukhtar, H
  • Anandamide induces cell death independently of cannabinoid receptors or vanilloid receptor 1: possible involvement of lipid rafts
    Sarker, KP; Maruyama, I
  • The combination of cannabidiol and Delta9-tetrahydrocannabinol enhances the anticancer effects of radiation in an orthotopic murine glioma model
    Scott, KA; Dalgleish, AG; Liu, WM
  • Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy
    Shrivastava, A; Kuzontkoski, PM; Groopman, JE; Prasad, A
  • Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma
    Singer, E; Judkins, J; Salomonis, N; Matlaf, L; Soteropoulos, P; McAllister, S; Soroceanu, L
  • Cannabidiol inhibits angiogenesis by multiple mechanisms
    Solinas, M; Massi, P; Cantelmo, AR; Cattaneo, MG; Cammarota, R; Bartolini, D; Cinquina, V; Valenti, M; Vicentini, LM; Noonan, DM; Albini, A; Parolaro, D
  • Delta9 tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells
    Srivastava, MD; Srivastava, BI; Brouhard, B
  • 2-Arachidonoylglycerol: a possible cannabinoid receptor ligand in the brain
    Sugiura, T; Kondo, S; Sukagawa, A; Nakane, S; Shinoda, A; Itoh, K; Yamashita, A; Waku, K
  • Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment
    Sui, X; Chen, R; Wang, Z; Huang, Z; Kong, N; Zhang, M; Han, W; Lou, F; Yang, J; Zhang, Q; Wang, X; He, C; Pan, H
  • Id1 cooperates with oncogenic Ras to induce metastatic mammary carcinoma by subversion of the cellular senescence response
    Swarbrick, A; Roy, E; Allen, T; Bishop, JM
  • Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target
    Timmerman, LA; Holton, T; Yuneva, M; Louie, RJ; Padro, M; Daemen, A; Hu, M; Chan, DA; Ethier, SP; van’t Veer, LJ; Polyak, K; McCormick, F; Gray, JW
  • A combined preclinical therapy of cannabinoids and temozolomide against glioma
    Torres, S; Lorente, M; Rodriguez-Fornes, F; Hernandez-Tiedra, S; Salazar, M; Garcia-Taboada, E; Barcia, J; Guzman, M; Velasco, G
  • Influence of anticonvulsant cannabinoids on posttetanic potentiation at isolated bullfrog ganglia
    Turkanis, SA; Karler, R
  • Constituents of Cannabis sativa L. XVII. A review of the natural constituents
    Turner, CE; Elsohly, MA; Boeren, EG
  • Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism
    Vaccani, A; Massi, P; Colombo, A; Rubino, T; Parolaro, D
  • Hypothesis: cannabinoid therapy for the treatment of gliomas?
    Velasco, G; Galve-Roperh, I; Sanchez, C; Blazquez, C; Guzman, M
  • Towards the use of cannabinoids as antitumour agents
    Velasco, G; Sanchez, C; Guzman, M
  • Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT(1A) receptors without diminishing nervous system function or chemotherapy efficacy
    Ward, SJ; McAllister, SD; Kawamura, R; Murase, R; Neelakantan, H; Walker, EA
  • Endocannabinoid signaling in the brain
    Wilson, RI; Nicoll, RA
  • Redox-directed cancer therapeutics: molecular mechanisms and opportunities
    Wondrak, GT
  • xCT inhibition depletes CD44v-expressing tumor cells that are resistant to EGFR-targeted therapy in head and neck squamous cell carcinoma
    Yoshikawa, M; Tsuchihashi, K; Ishimoto, T; Yae, T; Motohara, T; Sugihara, E; Onishi, N; Masuko, T; Yoshizawa, K; Kawashiri, S; Mukai, M; Asoda, S; Kawana, H; Nakagawa, T; Saya, H; Nagano, O
  • Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana
    Zhu, HJ; Wang, JS; Markowitz, JS; Donovan, JL; Gibson, BB; Gefroh, HA; Devane, CL
  • Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action
    Zuardi, AW

You’re reading a free preview. Subscribe to read the entire article.

Try 2 weeks free now

DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

or browse the journals available

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$499/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

Sign up
for free
Start 14 day
Free Trial